当前位置: X-MOL 学术J. Crohns Colitis › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry.
Journal of Crohn's and Colitis ( IF 8 ) Pub Date : 2020-03-23 , DOI: 10.1093/ecco-jcc/jjaa055
Margalida Calafat 1, 2 , Míriam Mañosa 1, 2, 3 , Francisco Mesonero 4 , Jordi Guardiola 5 , Miguel Mínguez 6 , Pilar Nos 3, 7 , Isabel Vera 8 , Carlos Taxonera 9 , Eva Iglesias 10 , Elena Ricart 3, 11 , Javier P Gisbert 3, 12 , Xavier Calvet 3, 13 , Santiago García-López 14 , David Monfort 15 , José Lázaro Pérez Calle 16 , Sabino Riestra 17 , Fernando Gomollón 3, 18 , Esther Garcia-Planella 19 , Fernando Bermejo 20 , Vicent Hernández 21 , María Dolores Martín-Arranz 22 , Ana Gutiérrez 3, 23 , Paola Torres 1 , Fiorella Cañete 1, 2, 3 , Eugeni Domènech 1, 2, 3 ,
Affiliation  

Although commonly used in inflammatory bowel disease [IBD], thiopurines frequently cause intolerance, and switching to a second thiopurine has only been reported in some small series. Ours aims in this study were to evaluate the safety of switching to a second thiopurine in a large cohort, and to assess the impact of age on tolerance.

中文翻译:

成人和老年炎症性肠病患者改用第二种硫嘌呤:来自 ENEIDA 登记处的一项全国性研究。

虽然通常用于炎症性肠病 [IBD],但硫嘌呤经常导致不耐受,并且仅在一些小系列报道中报道了改用第二种硫嘌呤。我们在本研究中的目的是评估在大型队列中改用第二种硫嘌呤的安全性,并评估年龄对耐受性的影响。
更新日期:2020-03-23
down
wechat
bug